Phathom Pharmaceuticals Inc. submitted two new drug applications (NDAs) to the U.S. Food and Drug Administration for the use of vonoprazan in combination with amoxicillin and clarithromycin (vonoprazan triple therapy) and vonoprazan in combination with amoxicillin (vonoprazan dual therapy) as a treatment for Helicobacter pylori infection in adults.

President Joe Biden on Sept. 9 will present a six-pronged strategy intended to fight the spread of the highly contagious coronavirus Delta variant and increase U.S. Covid-19 vaccinations, the White House said on Sept. 7.

75 percent of adults in the United States have received at least one dose of a Covid-19 vaccine as of the morning of Sept. 7, the U.S. Centers for Disease Control and Prevention said.

Data from Johns Hopkins University demonstrate that daily Covid-19 infections increased 316 percent from Labor Day 2020, or about four times more.

Indian drug developer Hetero received emergency use approval from the country’s health authorities to make a generic version of Roche Holding AG’s Covid-19 drug.

Former British prime minister Gordon Brown accused rich countries of committing a “moral outrage” by stockpiling Covid-19 doses while poor countries struggle to get supplies.

In a scene replayed across the United States, angry parents and activists streamed into a meeting of the Florida’s Lake County school board on Sept. 2 where it considered whether to mandate mask-wearing for students and staff due to Covid.

As cases of the Delta variant continue to raise concerns across the United States, a new variant reaches a warning level for the World Health Organization.

A study published in The Lancet Infectious Diseases found that the Pfizer-BioNTech, Oxford-AstraZeneca or Moderna vaccines resulted in a drop in “long-haul” Covid-19 by 50 percent. According to data collected by the American Academy of Pediatrics (AAP), more than 500,000 children tested positive in the United States for Covid-19 from August 5 to August 26.

A study published in the Journal of the American Medical Association by Belgium researchers comparing the Moderna and Pfizer-BioNTech Covid-19 vaccines found that the Moderna jabs generated twice the antibodies as the Pfizer-BioNTech vaccine.